Hetairos Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Mumbai, Maharashtra, India, established in 2022.
2022 Mumbai, Maharashtra, India Active
Last Updated:
About Hetairos Pharmaceuticals Private Limited

Hetairos Pharmaceuticals Private Limited, a active private limited company, was established on 18 January 2022 in Mumbai, Maharashtra, India. Engaging in medical appliances and instruments within the healthcare sector, it holds CIN: U33119MH2022PTC375079. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Jitendra Yadav (Director), Varsha Suresh Gupta (Additional Director). Past directors included Mubin Khan. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Mmf 13 1/1 Bh Pritam Ceramics, Nr. Neeldurg Hotel, Mukti Nagar, Chembur, Mumbai, Maharashtra, 400088.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33119MH2022PTC375079

  • Registration Number

    375079

  • Incorporation Date

    18 January 2022

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Hetairos Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hetairos Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Hetairos Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Jitendra Yadav Director 18 Jan 2022 Current
Varsha Suresh Gupta Additional Director 02 Aug 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 21 Aug 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hetairos Pharmaceuticals.

Enhance accessibility to Hetairos Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Hetairos Pharmaceuticals revenue growth over time
Hetairos Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hetairos Pharmaceuticals?

Unlock access to Hetairos Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Hetairos Pharmaceuticals?

Hetairos Pharmaceuticals has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hetairos Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetairos Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hetairos Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Hetairos Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Hetairos Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was documented.

  • Director Appointment

    Varsha Suresh Gupta was appointed as a Additional Director was appointed as a Additional Director on 02 Aug 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.

  • Director Appointment

    Progress on Jitendra Yadav was appointed as a Director was appointed as a Director on 18 Jan 2022 & has been associated with this company since 4 years 2 months . was documented.

  • Company Incorporation

    Progress on Hetairos Pharmaceuticals Private Limited was registered on 18 Jan 2022 with Roc Mumbai I & aged 4 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hetairos Pharmaceuticals Private Limited?

The CIN of Hetairos Pharmaceuticals Private Limited is U33119MH2022PTC375079.

Where is Hetairos Pharmaceuticals Private Limited headquartered?

Hetairos Pharmaceuticals Private Limited is headquartered at Mmf 13 1/1 Bh Pritam Ceramics, Nr. Neeldurg Hotel, Mukti Nagar, Chembur, Mumbai, Maharashtra, 400088.

When was Hetairos Pharmaceuticals Private Limited incorporated?

Hetairos Pharmaceuticals Private Limited was incorporated on 18 January 2022.

Who are the current directors of Hetairos Pharmaceuticals Private Limited?

The current directors of Hetairos Pharmaceuticals Private Limited are

What is the primary industry of Hetairos Pharmaceuticals Private Limited?

The primary industry of Hetairos Pharmaceuticals Private Limited is Healthcare.

Is Hetairos Pharmaceuticals Private Limited a listed company?

Hetairos Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Hetairos Pharmaceuticals Private Limited?

The authorized capital of Hetairos Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available